派罗替尼、曲妥珠单抗 (Zercepac®) 和长春瑞滨三线治疗 HER2 阳性晚期乳腺癌患者的脑转移。

{"title":"派罗替尼、曲妥珠单抗 (Zercepac®) 和长春瑞滨三线治疗 HER2 阳性晚期乳腺癌患者的脑转移。","authors":"Huan Wang, Bin Shao, Lijun DI","doi":"10.23736/S0026-4806.22.08236-2","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":18671,"journal":{"name":"Minerva medica","volume":" ","pages":"257-259"},"PeriodicalIF":4.7000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Third-line pyrotinib, trastuzumab (Zercepac®) and vinorelbine for brain metastases of HER2-positive advanced breast cancer patient.\",\"authors\":\"Huan Wang, Bin Shao, Lijun DI\",\"doi\":\"10.23736/S0026-4806.22.08236-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":18671,\"journal\":{\"name\":\"Minerva medica\",\"volume\":\" \",\"pages\":\"257-259\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Minerva medica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.23736/S0026-4806.22.08236-2\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/7/5 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"0\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva medica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.23736/S0026-4806.22.08236-2","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/7/5 0:00:00","PubModel":"Epub","JCR":"0","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}